Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35235

A clinical study for patients with Ulcerative Colitis

Birmingham Alabama 35294-3300

A clinical trial seeking patients for a Crohn's Disease treatment research study

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

Dothan Alabama 36305

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Dothan Alabama 36305

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

View More ▼

Dothan Alabama

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Huntsville Alabama 35801

A clinical study for patients with Ulcerative Colitis

Huntsville Alabama 35801

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mobile Alabama 36617

A clinical study for patients with Ulcerative Colitis

Mobile Alabama 36604

A clinical trial seeking patients for a Crohn's Disease treatment research study

Mobile Alabama 36604

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Arizona

Research Center
Sun City Arizona 85351

True North, a research study for adults 18-75 with ulcerative colitis.

Research Center
Tucson Arizona 85712

True North, a research study for adults 18-75 with ulcerative colitis.

View More ▼

Phoenix Arizona 85016

A clinical trial seeking patients for a Crohn's Disease treatment research study

Phoenix Arizona

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Phoenix Arizona 85016

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Phoenix Arizona 85016

A Phase 4 clinical study for patients with Inflammatory Bowel Disease

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Sun City Arizona 85351

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Tucson Arizona 85710

A clinical trial to evaluate treatments using LY3074828 and Placebo for patients with Crohn's Disease

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Research Center
North Little Rock Arkansas 72117

True North, a research study for adults 18-75 with ulcerative colitis.

View More ▼

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72117

A clinical research study of Stool collection

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Research Center
Anaheim California 92801

True North, a research study for adults 18-75 with ulcerative colitis.

Research Center
Lancaster California 93534

True North, a research study for adults 18-75 with ulcerative colitis.

Research Center
Mission Hills California 91345

True North, a research study for adults 18-75 with ulcerative colitis.

Research Center
San Diego California 92123

True North, a research study for adults 18-75 with ulcerative colitis.

View More ▼

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Beverly Hills California 90211

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Chula Vista California 91910

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Coronado California 92118

A clinical study for patients with Ulcerative Colitis

Encinitas California 92024

A clinical study for patients with Ulcerative Colitis

Garden Grove California 92843

A clinical trial to evaluate treatments using LY3074828 and Placebo for patients with Crohn's Disease

Garden Grove California

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease